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Abstract
Background: Our previous study showed that the NS1 protein of highly pathogenic avian influenza A virus H5N1
induced caspase-dependent apoptosis in human alveolar basal epithelial cells (A549), supporting its function as a
proapoptotic factor during viral infection, but the mechanism is still unknown.
Results: To characterize the mechanism of NS1-induced apoptosis, we used a two-hybrid system to isolate the
potential NS1-interacting partners in A549 cells. We found that heat shock protein 90 (Hsp90) was able to interact
with the NS1 proteins derived from both H5N1 and H3N2 viruses, which was verified by co-immunoprecitation
assays. Significantly, the NS1 expression in the A549 cells dramatically weakened the interaction between Apaf-1
and Hsp90 but enhanced its interaction with cytochrome c (Cyt c), suggesting that the competitive binding of NS1
to Hsp90 might promote the Apaf-1 to associate with Cyt c and thus facilitate the activation of caspase 9 and
caspase 3.
Conclusions: The present results demonstrate that NS1 protein of Influenza A Virus interacts with heat hock
protein Hsp90 and meidates the apoptosis induced by influenza A virus through the caspase cascade.
Background
Influenza A virus is a globally important human and ani-
mal respiratory pathogen responsible for both seasonal
influenza outbreaks and periodic world-wide pandemics.
Its genome contains eight segmented and negative-
stranded RNAs encoding a total of eleven proteins (HA,
NA, NP, M1, M2, NS1, NEP, PA, PB1, PB1-F2, PB2). The
NS1 is a 26,000 dalton non-structural protein expressed
only within the infected cells. It is accumulated in the
cell nucleus at early times during infection and can be
presented in the cytoplasm at latter times. Previous stu-
dies have demonstrated that the NS1 protein is an
important molecular determinant of virulence factor and
contributes significantly disease pathogenesis by modu-
lating a number of virus and host-cell processes [1-4].
For example, it can inhibit nuclear export of polyadeny-
lated mRNAs, bind to small nuclear RNA (snRNA) and
block pre-mRNA splicing, and suppress the interferon
response in the virus-infected cell leading to unimpaired
virus production.
Many virus infections induce apoptosis of host cells
while some viruses have evolved mechanisms to inhibit
apoptotic events. It has been demonstrated that influenza
A viruses can result in apoptosis in numerous cell types,
both in vivo [5-7] and in vitro [8-16], but the mechanism
of virus-induced apoptosis is not well known. Several
viral factors, including neuraminidase, M1, NS1, NA and
PB1-F2, from different strains of human influenza viruses
have been reported to be related apoptosis induction
[17-22]. The NS1 protein of influenza A viruses was
shown to induce apoptosis in human cells [13,23], but
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any medium, provided the original work is properly cited.some observations, in a sharp contrast, suggested its role
in inhibiting apoptosis [11,21 ] .O b v i o u s l y ,t h e s ec o n t r a -
dictory results might be caused by the differences of virus
subtypes and strains, as well as the host cell systems
being used, highlighting further investigations are needed
to clarify whether the NS1 protein is a proapoptotic or
antiapoptotic factor in infected cells [24]. We have
recently showed that the NS1 protein of highly patho-
genic avian influenza A virus H5N1 could induce
caspase-dependent apoptosis in human alveolar basal
epithelial cells (A549), supporting its function as a proa-
poptotic factor during viral infection [25]. In this study,
our main purpose was to characterize the molecular
mechanism of NS1-induced apoptosis. First, we con-
firmed further that the NS1 protein is a strong inducer of
apoptosis by using an H3N2 strain. With a two-hybrid
system and co-immunoprecitation assays we identified
the heat shock protein 90 (Hsp90) as a binding partner
for the NS1 protein of both H5N1 and H3N2 strains.
Furthermore, our data suggested that the NS1-Hsp90
interaction might competitively promote the association
of Apaf-1 with Cyt c and thus activate the caspase
cascade.
Materials and methods
Viruses and cells
Influenza A/chicken/Jilin/2003(H5N1)and A/swine/Col-
orado/1/1977(H3N2)viruses were grown in the allantoic
cavities of 10-day-old embryonated chicken eggs. A549
cells were passaged in Dulbecco’s modified Eagle’s tissue
culture medium (DMEM) containing 10% fetal calf
s e r u ma t3 7 ° Ci na5 %C O 2 incubator. The confluent
cell monolayers grown in 25-mm dishes were lysed in
immunoprecipitation assay buffer containing 150 mM
NaCl, 1.0% Nonidet P-40 (NP-40), 0.5% deoxycholate,
0.1% sodium dodecyl sulfate (SDS), and 50 mM Tris-
HCl (pH 8.0). The cell lysates were clarified by centrifu-
gation for 10 min at 13,000 × g, and the supernatants
were used for immunoblot analysis.
Construction of expression plasmids
Total RNA was extracted from the cell lysate using the
QIAamp viral RNA mini kit (Qiagen, Hilden, Germany).
The full-length NS1 gene from H5N1 or H3N2 were
amplified using the SuperScript III one-step reverse tran-
s c r i p t i o n - P C R( R T - P C R )s y s t e mw i t hP l a t i n u mTaq
high-fidelity polymerase (Invitrogen, Carlsbad, CA) and
ligated into pSos vector according to the protocol of the
vector manufacturer (Invitrogen). Clones were screened
by PCR and sequencing. Competent Escherichia coli
DH5a cells were transformed with the plasmids, and the
plasmids were amplified and purified using a high-purity
plasmid purification kit (Qiagen). The constructions of
expression plasmids, including pCMV-myc/NS1 (H5N1
or H3N2), pCMV-Flag/Hsp90, pSos/NS1 (H5N1 or
H3N2), pBIND/NS1 (H5N1 or H3N2), pACT/Hsp90 fol-
lowed standard cloning procedures. 5NS1 denotes the
NS1 derived from H5N1, 3NS1 denotes the NS1 from
H3N2.
Electron microscopic analysis
A549 cells were transfected with pCMV-myc/3NS1 by
using Lipofectamine 2000 reagent (Invitrogen). After
24 h, cells were collected, digested, washed with phos-
phate buffered solution (PBS), fixed with 4% glutaralde-
hyde for 2 h, and then fixed with osmium tetroxide for
1 h, stained with uranium acetate, embedded into epox-
ide resin. After sectioning into ultra-thin slices, the cells
were stained with lead citrate and examined under
transmission electron microscopy (TECNAI10).
Flow cytometric analysis
To determine the apoptosis rate, an Annexin V-FITC
apoptosis detection kit (BD Pharmingen, San Diego, CA)
was used to detect early apoptotic activity according to
the manufacturer’s instruction, with slight modifications.
After 24 h transfected as described above, A549 cells
were harvested and washed twice with ice-cold PBS and
resuspended in 100 ml of binding buffer. A total of 5 ml
of Annexin V-FITC and 10 ml of propidium iodide (PI)
were added and the mixture was incubated for 30 min in
the dark. Finally, the binding buffer was added to the
cells and the mixture was analyzed with a Flow cytometer
(Becton Dickinson Co., San Jose, CA), using an FITC
signal detector (FL1) for Annexin V staining and a
phycoerythrin emission signal detector for PI staining.
The apoptotic percentage of 10,000 cells was determined.
All the experiments reported in this study were per-
formed three times. The data were analyzed by using
WinMDI 2.8 software (Scripps Institute, La Jolla, CA) for
calculation of percentage cells with apoptosis per group.
Expression of caspase-9 and caspase-3
The expression of caspase-9 and caspase-3 in the NS1-
transfected A549 cells was measured by Western-blot ana-
lysis. Briefly, the monolayer of cells transfected with
pCMV-myc/3NS1 were lysed with ice-cold lysis buffer
(150 mM Tris-HCl, pH 8.0, 50 mM NaCl, 1 mM EDTA,
0.5% Nonidet P-40, 1 tablet Complete Mini protein inhibi-
tor mixture/10 ml (Roche Applied Science, Indianapolis,
IN) and 0.7 μg/ml pepstatin), and the cell lysates were
clarified by centrifugation at 20,000 g for 10 min at 4°C.
The caspase-9 and caspase-3 activities were determined
according to the supplemental protocols of the Caspase-9/
Mch6 Colorimetric Assay kit and Caspase-3/CPP32 Col-
orimetric Protease Assay kit (MBL, Nagoya, Japan),
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release of pNA (405nm), was measured using a Multiskan
Ascent plate reader.
Isolation of NS1-binding partners by CytoTrap two-hybrid
system
The CytoTrap two-hybrid system (Stratagene, La Jolla,
CA) was used to screen a human fetal lung plasmid
cDNA library which has 5.3 × 10
6 primary colonies and
an average insert size of 1.2 kb according to the manu-
facturer’s instructions (Stratagene). The NS1 gene of
H5N1 or H3N2 was fused to the N-terminal 1070 resi-
dues of human Sos and used as a bait. The prey cDNAs
were fused to the myristoylation signal of v-Src that
anchors the fusion proteins to the plasma membrane.
The cdc25H was firstly co-transformed with pSos-5NS1
or pSos-3NS1 together with pYES-mGAP to reduce iso-
lation of Ras GTPase false positive clones. The pretrans-
formed cdc25H was then transformed with 3 μgo f
pMyr-cDNA library plasmids for the CytoTrap screen-
ing. The resulting transformants were grown for 5 days
at 22°C on selective minimal glucose plates (complete
supplement mixture-LEU-URA-TRP). After plating the
replica onto the selective minimal galactose plates, the
colonies that showed galactose-dependent growth under
restrictive conditions were selected for plasmid prepara-
tion. The isolated plasmid was then transformed into
Escherichia coli DH5a and selected on 50 ng/μlc h l o r -
amphenicol for the presence of the cDNA insert-con-
taining pMyr plasmid. The protein interactions of
putatively positive colonies were confirmed by retrans-
formation of the cdc25H yeast strain with both the
cDNA-containing pMyr plasmid and pSos-5NS1 or
pSos-3NS1. The empty pSos was used as a negative con-
trol. Only those clones growing on galactose media at
the restrictive temperature of 37°C after 6 days were
defined as true positives. Co-transformation of cdc25H
cells with pSos-MafB and pMyr-target cDNA, pSos and
pMyr-target cDNA, pSos-MafB and pMyr-Lamin C,
pSos and pMyr, pSos-5NS1and pMyr-Lamin C, and
pSos-5NS1 and pMyr served as negative controls,
whereas co-transformation of cdc25H cells with pSos-
MafB and pMyr-MafB served as a positive control.
Mammalian two-hybrid system
The CheckMate mammalian two-hybrid system (Promega,
Madison, WI) was used to characterize the protein inter-
actions in the mammalian cells. In this system, the pBind
vector contains the yeast GAL4 DNA-binding domain
upstream of a multiple cloning region. The pACT vector
contains the herpes simplex virus VP16 activation domain
upstream of a multiple coding region. The NS1 and
Hsp90 genes were cloned into the pBind and pACT vec-
tors to generate fusion proteins with the GAL4 DNA-
binding domain and the VP16 activation domain, respec-
tively. The pG5luc vector contains five GAL4 binding sites
upstream of a minimal TATA box, which in turn is
upstream of the firefly luciferase gene (luc+). The pGAL4
and pVP16 fusion constructs were transfected along with
the pG5luc vector into mammalian cells. The plasmids
were co-transfected using Lipofectamine 2000 reagent
(Invitrogen) according to the manufacturer’sp r o t o c o li n
the following combinations: 1) pACT vector + pBind vec-
tor + pG5luc vector; 2) pACT vector + pBind-5NS1(or
-3NS1) vector + pG5luc vector; 3) pACT-Hsp90 vector +
pBind vector + pG5luc vector; 4) pACT-Hsp90 vector +
pBind-5NS1(or -3NS1) vector + pG5luc vector; 5) pACT-
MyoD + pBind-Id + pG5luc vector; 6) blank control. After
transfection 24h, the cells were lysed and the luciferase
activity was quantitated according to the method
described previously (Miranda et al., 1993). Briefly, 10 μl
cell lysates were added to 100 μl1 m MA T P( S i g m a ,
Buchs, Switzerland)/10mM MgAc/0.1mg/ml BSA in
250mM Tris-HCl, pH 7.5. Samples were injected with
100 μl 200 μg coenzyme A/30 μg luciferine (Sigma)/ml in
12.5mM PIPES, pH 6.5 and light emission was measured
after a delay of 0.3s during a 10s interval in a MicroLumat-
Plus luminometer (Berthold Technologies, Bad Wildbach,
Germany). All experiments were performed at least three
times and the samples were measured in duplicates.
Co-immunoprecipitation assays
To study the interaction between NS1 protein and Hsp90,
1.2 × 10
6 A549 cells cultured in DMEM containing 10%
fetal calf serum were cotransfected with pCMV-Flag/
Hsp90 and pCMV-myc/5NS1 or pCMV-myc/3NS1 using
Lipofectamine 2000 reagent (Invitrogen) according to the
manufacturer’s protocol. After a 24 h incubation, cells
were lysed with ice-cold lysis buffer (150mM Tris-HCl,
pH 8.0, 50mM NaCl, 1 mM EDTA, 0.5% Nonidet P-40, 1
tablet Complete Mini protein inhibitor mixture/10 ml
(Roche Applied Science), and 0.7 μg/ml pepstatin), and
the lysates were clarified by centrifugation at 20,000 g for
10 min at 4°C. Supernatants were applied to 50 μl of anti-
Myc agarose or anti-Flag agarose (Sigma) respectively and
incubated overnight at 4°C. Subsequently, the immunopre-
cipitates were washed three times with washing buffer
(50mM Tris-HCl, pH 7.5, 250mM NaCl) and subjected
together with total lysates to SDS-PAGE and immunoblot
analysis. Proteins were detected using HRP-conjugated
mouse monoclonal anti-Flag antibody (1:3500) and anti-
Myc antibody (1:4000; Sigma) or rabbit anti-NS1 serum
(1:1000) followed by incubation with HRP-conjugated
anti-rabbit antibody (1:5000; Amersham Biosciences). To
analyze whether the NS1 expression affects the interaction
between Hsp90 and Apaf-1 or between Cyt c and Apaf-1,
the co-immunoprecitation assays were similarly per-
formed. Briefly, the A549 cells were transfected with the
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above, the cell supernatants were prepared and applied to
anti-Hsp90 agarose or anti-Cyt c agarose. The immuno-
precipitates were detected by immunoblotting with HRP-
conjugated goat anti-Apaf-1 antibody.
Results
Expression of NS1 protein induced apoptosis in A549
cells
We have recently reported that the NS1 protein of H5N1
could induce caspase-dependent apoptosis in A549 cells.
Here, we sought to clarify whether the NS1 of influenza
A/swine/Colorado/1/1997, a H3N2 strain, could induce
apoptosis. After the plasmid pCMV-myc/3NS1 was
transfected into A549 cells, we examined the morpholo-
gical and ultrastructural features of the transfected cells.
Figure 1A shows the empty vector-transfected cells with
normal silhouettes, but the NS1-transfected cells appear
to be characteristics of apoptotic cells, including nuclear
condensation, chromatin aggregation to the nuclear
membrane and the apoptotic bodies in some cells (Figure
1B). The NS1-transfected A549 cells were stained with
annexin V-FITC and PI and analyzed by flow cytometry.
Compared to the empty vector-transfected cells (Figure
1C shows 2.11% Annexin V
+/PI
- and 5.23% Annexin V
+/
PI
+ ), the NS1-transfected cells were 7.46% Annexin V
+/
PI
- (early apoptosis) and 9.75% Annexin V
+/PI
+ (latter
apoptosis).
We then investigated whether the caspase pathways
were involved in the apoptosis induced by H3N2 NS1
proteins. The A549 cells were transfected with the NS1-
expressing plasmid and the cell lysates were prepared.
The expression of caspase-9 and caspase-3 was detected
by Western-blotting. As shown in Figure 1E, both apop-
tosis-related caspase-9 and caspase-3 were activated in
the transfected A549 cells. The active fragments of cas-
pase-9 and caspase-3 could be detected at post-transfec-
tion 12, 24, and 48 hrs. The enzyme activities of
caspase-9 and caspase-3 were further measured and the
results showed that both apoptotic enzymes were acti-
vated in the NS1-transfected A549 cells (Figure 1F).
These data confirmed that the NS1 protein of influenza
A virus H3N2, like that of H5N1, induced caspase-
dependent apoptosis in the transfected A549 cells.
Identification of Hsp90 as a NS1-binding partner
To explore the mechanism of influenza A virus NS1
protein-induced apoptosis, we used the CytoTrap two-
hybrid system to isolate the potential NS1-interacting
proteins. This system was developed to greatly increase
the opportunities for identifying unique protein-protein
interactions by taking the search to the yeast cytoplasm.
Unlike in the nucleus, the proteins expressed in the
cytoplasm may undergo posttranslational modifications.
The coding region of H5N1 or H3N2 NS1 gene was
used in the CytoTrap screen. The yeast cells expressing
the Sos-NS1 were transformed with a human lung
cDNA library. The prey was expressed as a fusion pro-
tein with a myristylation sequence that anchors the
fusion protein onto the plasma membrane. If the bait
protein physically interacted with the prey protein, Sos
was recruited to the membrane, where activates the
yeast RAS-signaling pathway and allows cdc25Ha to
grow at 37°C. A total of 24 colonies of ~2.2 million
transformants showed galactose-dependent growth
under restrictive conditions. Only those clones showing
NS1 dependent growth were defined as true positives.
One clone was identified to encode an apoptosis-related
protein, Hsp90 (Figure 2). Further experiments con-
firmed that Hsp90 was a target protein of the NS1 bait
derived from both H5N1 and H3N2.
Characterization of NS1 and Hsp90 interaction
First, we characterized the interaction between the NS1
and hsp90 by using a mammalian two-hybrid system.
The NS1 (H5N1 or H3N2) and Hsp90 genes were
cloned into the pBIND and pACT vectors to generate
fusion proteins with the GAL4 DNA-binding domain
(pBind-NS1) and the VP16 activation domain (pACT-
Hsp90), respectively. The pBind-NS1 and pACT-Hsp90
were cotransfected along with the pG5luc vector into
A549 cells. The interaction of the two clock components
reconstitutes a functional transcription factor that acti-
vates a luciferase reporter under the control of a GAL4-
based promoter. For GAL4-NS1 of H5N1/Hsp90-VP16,
several-folds increase in luciferase activity was observed
(Figure 3A). Similar values were also obtained for
GAL4-NS1 of H3N2/Hsp90-VP16 (Figure 3B). However,
only a minimal activation of the reporter was seen when
GAL4-NS1 of H5N1 or H3N2 was expressed alone or
together with an unrelated fusion protein (VP16) or
when the VP16 fusions were co-transfected with the
Gal4 DBD alone. These results confirmed that the NS1
protein can interact with Hsp90 in A549 cells.
We then performed co-immunoprecipitation experi-
ments to further verify the interaction between the NS1
(H5N1 or H3N2) and Hsp90 in A549 cells. The Myc-
tagged NS1and pCMV-Flag/Hsp90 were co-expressed in
A549 cells. The lysates of the transfected cells were ana-
lyzed. First, NS1 protein was precipitated with polyclonal
anti-Myc antibodies and Hsp90 was detected by immuno-
blotting with polyclonal anti- Flag antibodies. It was found
that the Hsp90 could be detected in the anti-Myc immu-
noprecipitates. Simultaneously, the Hsp90 was precipitated
from the cell lysates with anti-Flag and the NS1 was
detected with anti-Myc (Figure 4A and Figure 4B). Consis-
tently, the NS1 and Hsp90 proteins could be co-immuno-
precipitated. These results demonstrated that Hsp90 was a
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Page 4 of 9Figure 1 Influenza A virus NS1 protein induces apoptosis in A549 cell. The transmission electron microscopy reveals that the cells
transfected with pCMV-Myc empty vector shows an intact nuclear shape (A) and transfected with pCMV-Myc/3NS1 shows condensed, shrunk
chromatins aggregated along inside the nuclear membrane, and apoptotic bodies (B). The flow cytometric analysis of A549 cells transfected with
the empty pCMV-Myc vector (C) or transfected with pCMV-Myc/3NS1 (D). The dot plot diagrams represent typical apoptotic and necrotic cell
populations detected by Annexin V-FITC and PI staining. The lower left quadrants of the panels show viable intact cells, which were negative for
Annexin V-FITC binding and excluded PI staining (FITC
-/PI
-); the upper right quadrants show nonviable, necrotic cells, which were positive for
Annexin V-FITC binding and PI uptake (FITC
+/PI
+). The lower right quadrants represent apoptotic cells, positive for Annexin V-FITC and negative
for PI (FITC
+/PI
-). The expression of caspase 3 and caspase 9 posttransfection 0 h, 12 h, 24 h, and 48 h were detected by Western blotting (E),
and the enzyme activities of caspase-3 and caspase-9 in the NS1-transfected A549 cells were detected by Caspase-3/CPP32 Colorimetric Protease
Assay and Caspase-9/Mch6 Colorimetric Assay, respectively (F).
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both H5N1 and H3N2.
The NS1 expression weakened the interaction of Apaf-1
with Hsp90
It is known that Hsp90 can inhibit caspase-depenent
apoptosis by its interaction with Apaf-1. We hypothe-
sized that the NS1 expression might compete with
Apaf-1 for Hsp90 binding and thus promote the activa-
tion of caspases through its interaction with Cyt c. To
this end, we applied the co-immunoprecipitation assays
to investigate whether the NS1 could affect Apaf-1 in
the A549 cells. The plasmids expressing H5N1 NS1
(pCMV-myc/5NS1) or H3N2 NS1 (pCMV-myc/3NS1)
were transfected into the cells for 24 hours and the cell
lysates were incubated with anti-Hsp90 antibodies or
anti-Cyt c antibodies. The resulting immunoprecipitates
were analyzed by immunoblotting with anti-Apaf-1 anti-
bodies. As shown in Figure 5, the quantity of Apaf-1
bound to Hsp90 was dramatically decreased in the NS1-
transfected cells, whereas the quantity of Apaf-1 bound
to Cyt c dramatically increased. As a control, the
expression of b-actin had no changes in the NS1-trans-
fected cells compared to the empty vector-transfected
cells. These data suggested that the competitive interac-
tion between NS1 and Hsp90 might promote the bind-
ing of Apaf-1 to Cyt c, implying a novel pathway for the
NS1-mediated caspase cascade during the apoptosis
induced by influenza A virus.
Discussion
In this study, we continued our studies to characterize
the functionality and mechanism of influenza A virus
NS1 protein in the virus-induced apoptosis. The NS1
g e n ew a sc l o n e df r o mt h ei n f l u e n z aA / s w i n e / C o l o r a d o /
1/1997 (H3N2) and expressed in the A549 cells. Consis-
tent with our previous studies from the NS1 protein of
highly pathogenic avian influenza A virus H5N1 [25],
the H3N2 NS1 protein was also capable to cause
Figure 2 Identification of NS1-Hsp90 interaction in yeast by the
CytoTrap two-hybrid system. Various bait (pSos) and prey (pMyr)
plasmids were used for co-transformation of cdc25H yeast cells,
representing a positive control (lane 1) and negative controls (lanes
2-7). Five independent cdc25H transformants were spotted on
glucose (GLU) medium at 22°C (left panel) or 37°C (middle panel)
and on galactose (GAL) medium at 37°C (right panel). Yeast
transformants expressing NS1 (H5N1 and H3N2) and Hsp90 grew
efficiently on galactose medium at 37°C (right panel, lane 8). 5NS1
represents H5N1 NS1 and 3NS1 represents H3N2 NS1.
Figure 3 Characterization of the NS1-Hsp90 interaction in A549
cells by mammalian two-hybrid system. pACT Vector, pBIND
Vector, pBIND-5NS1(or -3NS1) Vector, pACT-Hsp90 and the indicated
expression plasmids were co-transfected A549 cells as groping of
described above. The values represent the average from three
independent experiments for each group.
Figure 4 Characterization of the NS1-Hsp90 interaction in A549
cells by Coimmunoprecipitation. A549 cells were co-transfected
with the plasmids encoding Myc-tagged NS1 (A. H5N1; B. H3N2)
and Flag -tagged Hsp90. Cell lysates were immunoprecipitated with
anti-Myc antibody to capture NS1 and coimmunoprecipitated Hsp90
was detected by immunoblotting with anti-Hsp90 antibody. Lysates
were prepared as in described above, but immunoprecipitated with
anti Flag antibody to capture Hsp90, and the associated NS1 of
H5N1 was detected by immunoblotting with anti-Myc antibody.
(5NS1 represent NS1 of influenza H5N1; 3NS1 represent NS1 of
influenza H3N2).
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enzymes, caspase-9 and caspase-3, were significantly
activated in the transfected A549 cells. We were
attracted to know the signal pathway of NS-1-induced
caspase-dependent apoptosis. In an effort to search for
the possible interacting partners of the NS1 protein in
the A549 cells, we decided to use the CytoTrap two-
hybrid system. This approach was designed to isolate
the binding partner in the yeast cytoplasm rather than
in the nucleus and provide a novel method for detecting
protein-protein interactions in vivo. To our knowledge,
it had not been used to identify the NS1-interacting pro-
teins. In addition, the use of A549 cells might also pro-
vide more chance to find novel targets. In deed, a
number of binding partners were hooked out from the
human lung cDNA library. Among them we focused on
the heat shock protein Hsp90 because it was the only
known protein involved in the apoptosis. Consistently,
the physiological protein-protein interaction between
the NS1 protein and Hsp90 was verified by the mamma-
lian two-hybrid system and co-immunoprecipitation
assays.
Similar to other heat shock proteins, Hsp90 is a con-
stitutively abundant molecular chaperone that controls
the conformation, stability, activation, intracellular
distribution, and turnover of numerous client proteins
and involved in cell growth, differentiation, and survival
[26,27]. The cytoprotective function of Hsp90 is largely
explained by its anti-apoptotic effect. It has been shown
that overexpression of Hsp90 can prevent apoptosis trig-
gered by various stimuli [28,29], whereas downregula-
tion or inhibition of its expression is enough to sensitize
cells to apoptosis [30-32]. Recently, there is ample evi-
dence to show that Hsp90 plays critical roles in viral
replication, and that inhibitors for Hsp90 can impair the
growth of many viruses [33-36]. In the case of influenza
A virus, Hsp90 was shown to play a role in the nuclear
import and assembly of viral RNA polymerase complex
by binding to the PB1 and PB2 subunits, and Hsp90
inhibitors geldanamycin and its derivative 17-AAC
could inhibit viral growth at early time points [33,37].
Therefore, the identification of Hsp90 as a NS1 protein
interacting partner has provided a new clue for explor-
ing the mechanism of influenza virus-induced apoptosis.
Structurally, Hsp90 contains three functional domains:
the ATP binding domain near the N-terminus, protein
binding domain located towards the C-terminus of the
amino sequence, and dimerizing domain [38]; the multi-
functional protein NS1 contains the N-terminal RNA-
binding domain and the C-terminal effector domian and
participates in both protein-protein and protein-RNA
interactions [39]. How these two molecules physically
contact in the cells remains to be further characterized.
The molecular motifs responsible for the interaction can
help to define their functions in the apoptotic induction.
Previous studies demonstrated that Hsp90 can interact
with key client proteins of the apoptotic pathways includ-
ing a number of signaling proteins like ligand-depentent
transcription factors and signal transducing kinases
[26,27,40-42]. Most importantly, Hsp90 can associate
directly with Apaf-1 and competitively block binding of
Cyt c to Apaf-1, thereby inhibiting oligomerization of
Apaf-1 [26,29]. Competition of Hsp90 and Cyt c for bind-
ing to Apaf-1 provides a mechanistic explanation for why
cells overexpressing Hsp90 are highly resistant to Cyt
c-mediated activation of caspase cascade. Therefore, we
asked whether the NS1 expression affects the interaction
of Hsp90 and Apaf-1 and thereby to induce apoptosis.
Our results demonstrated that the interaction between
NS1 and Hsp90 could competitively decrease the associa-
tion of Apaf-1 and Hsp90 but increase the association of
Apaf-1 and Cyt c. Based on the results we propose a
model for the NS1-induced apoptosis (Figure 6): the
binding of NS1 and Hsp90 might compete off the Apaf-1,
resulting in the oligomerization of Apaf-1 which by turn
promotes the interaction between Apaf-1 and Cyt c, and
lead to the activation of caspase 9 and caspase 3 and cell
apoptosis occur. Although many works are needed to
prove the present model, our data might reveal a novel
Figure 5 The NS1 expression affects the interaction of Apaf-1
with hsp90 or Cyt c. The plasmids expressing H5N1 NS1 (pCMV-
myc/5NS1) or H3N2 NS1 (pCMV-myc/3NS1) were transfected into
cells for 24 hours and the cell lysates were incubated with anti-
Hsp90 antibodies or anti-Cyt c antibodies. The resulting
immunoprecipitates were analyzed by immunoblotting with anti-
Apaf-1 antibodies.
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the apoptosis induced by influenza A virus.
The outbreak of current new strain of influenza A virus
s u b t y p eH 1 N 1a n dt h ee p i d e m i co fh i g h l yp a t h o g e n i c
avian influenza A virus H5N1 in the past years highlight
that the influenza A viruses are globally important
human and animal respiratory pathogens, and their
detailed characterization is needed to facilitate our
understanding for the disease pathogenesis and to help
developing the vaccines and therapeutics. One can pre-
dict that any inhibitors that prevent the NS1-mediated
apoptosis pathway would reduce disease severity and
improve clinical outcomes.
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